Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Functional capacity of Shiga-toxin promoter sequences in eukaryotic cells.

Bentancor LV, Bilen MF, Mejías MP, Fernández-Brando RJ, Panek CA, Ramos MV, Fernández GC, Isturiz M, Ghiringhelli PD, Palermo MS.

PLoS One. 2013;8(2):e57128. doi: 10.1371/journal.pone.0057128. Epub 2013 Feb 22.

2.

Promoter sequence of Shiga toxin 2 (Stx2) is recognized in vivo, leading to production of biologically active Stx2.

Bentancor LV, Mejías MP, Pinto A, Bilen MF, Meiss R, Rodriguez-Galán MC, Baez N, Pedrotti LP, Goldstein J, Ghiringhelli PD, Palermo MS.

MBio. 2013 Oct 1;4(5):e00501-13. doi: 10.1128/mBio.00501-13.

3.

A DNA vaccine encoding the enterohemorragic Escherichia coli Shiga-like toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine model.

Bentancor LV, Bilen M, Brando RJ, Ramos MV, Ferreira LC, Ghiringhelli PD, Palermo MS.

Clin Vaccine Immunol. 2009 May;16(5):712-8. doi: 10.1128/CVI.00328-08. Epub 2009 Jan 28. Erratum in: Clin Vaccine Immunol. 2010 Aug;17(8):1291.

4.

Immunoprophylactic potential of cloned Shiga toxin 2 B subunit.

Marcato P, Mulvey G, Read RJ, Vander Helm K, Nation PN, Armstrong GD.

J Infect Dis. 2001 Feb 1;183(3):435-43. Epub 2000 Dec 27.

PMID:
11133375
6.

Phylogenetic analysis and Shiga toxin production profiling of Shiga toxin-producing/enterohemorrhagic Escherichia coli clinical isolates.

Li R, Harada T, Honjoh K, Miyamoto T.

Microb Pathog. 2010 Nov;49(5):246-51. doi: 10.1016/j.micpath.2010.06.005. Epub 2010 Jun 15.

PMID:
20558273
7.

Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome.

Orth D, Khan AB, Naim A, Grif K, Brockmeyer J, Karch H, Joannidis M, Clark SJ, Day AJ, Fidanzi S, Stoiber H, Dierich MP, Zimmerhackl LB, Würzner R.

J Immunol. 2009 May 15;182(10):6394-400. doi: 10.4049/jimmunol.0900151.

8.

Genetic characterization of Escherichia coli O157: H7/- strains carrying the stx2 gene but not producing Shiga toxin 2.

Koitabashi T, Vuddhakul V, Radu S, Morigaki T, Asai N, Nakaguchi Y, Nishibuchi M.

Microbiol Immunol. 2006;50(2):135-48.

9.

Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm?

Bielaszewska M, Köck R, Friedrich AW, von Eiff C, Zimmerhackl LB, Karch H, Mellmann A.

PLoS One. 2007 Oct 10;2(10):e1024.

10.
11.

Large-scale preparation of Shiga toxin 2 in Escherichia coli for toxoid vaccine antigen production.

Arimitsu H, Sasaki K, Shimizu T, Tsukamoto K, Shimizu T, Tsuji T.

Microbiol Immunol. 2013 Jan;57(1):38-45. doi: 10.1111/j.1348-0421.2012.12004.x.

12.

The Shiga toxin 2 B subunit inhibits net fluid absorption in human colon and elicits fluid accumulation in rat colon loops.

Creydt VP, Miyakawa MF, Martín F, Zotta E, Silberstein C, Ibarra C.

Braz J Med Biol Res. 2004 Jun;37(6):799-808. Epub 2004 May 27.

14.

Development and characterization of monoclonal antibodies against Shiga toxin 2 and their application for toxin detection in milk.

He X, McMahon S, Skinner C, Merrill P, Scotcher MC, Stanker LH.

J Immunol Methods. 2013 Mar 29;389(1-2):18-28. doi: 10.1016/j.jim.2012.12.005. Epub 2012 Dec 30.

PMID:
23279946
15.

Construction of a novel bioluminescent reporter system for investigating Shiga toxin expression of enterohemorrhagic Escherichia coli.

Shimizu T, Ohta Y, Tsutsuki H, Noda M.

Gene. 2011 Jun 1;478(1-2):1-10. doi: 10.1016/j.gene.2011.01.006. Epub 2011 Jan 22. Review.

PMID:
21262333
16.

Protection against Shiga toxin-producing Escherichia coli infection by transcutaneous immunization with Shiga toxin subunit B.

Zhu C, Yu J, Yang Z, Davis K, Rios H, Wang B, Glenn G, Boedeker EC.

Clin Vaccine Immunol. 2008 Feb;15(2):359-66. Epub 2007 Nov 14.

17.

Characterization of rabbit polyclonal sera against recombinant Shiga toxin and its subunits for detection of Stx-producing E. coli.

Oloomi M, Bouzari S.

Iran J Allergy Asthma Immunol. 2011 Mar;10(1):41-6. doi: 010.01/ijaai.4146.

18.

Shiga toxin 2 is specifically released from bacterial cells by two different mechanisms.

Shimizu T, Ohta Y, Noda M.

Infect Immun. 2009 Jul;77(7):2813-23. doi: 10.1128/IAI.00060-09. Epub 2009 Apr 20.

19.

Escherichia coli Shiga toxin.

Nakao H, Takeda T.

J Nat Toxins. 2000 Aug;9(3):299-313. Review.

PMID:
10994531
20.

Structure of shiga toxin type 2 (Stx2) from Escherichia coli O157:H7.

Fraser ME, Fujinaga M, Cherney MM, Melton-Celsa AR, Twiddy EM, O'Brien AD, James MN.

J Biol Chem. 2004 Jun 25;279(26):27511-7. Epub 2004 Apr 9. Erratum in: J Biol Chem. 2006 Dec 22;281(51):39740.

Supplemental Content

Support Center